LIVE

Serial Number

78087563

Owner

DECON LABORATORIES, INC.

First Use Date

Sep 15, 2001

Filing Date

Oct 9, 2001

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

WFI QUALITY IN ENDOTOXIN LIMITS WFI Q Trademark

Serial Number: 78087563 • Registration: 2628408

WFI QUALITY IN ENDOTOXIN LIMITS WFI Q is a trademark filed by DECON LABORATORIES, INC. on October 9, 2001. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

DECON LABORATORIES, INC. (27 trademarks)

King of Prussia, PA 19406

Entity Type: 03

Trademark Details

Filing Date

October 9, 2001

Registration Date

October 1, 2002

First Use Anywhere

September 15, 2001

First Use in Commerce

October 1, 2001

Published for Opposition

July 9, 2002

Goods & Services

ISOPROPYL AND ETHANOL BASED DISINFECTANTS USED TO DISINFECT SURFACES, MEDICAL EQUIPMENT AND INSTRUMENTS IN CLEANROOMS AND LABORATORIES

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Apr 4, 2023 NA89

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

Apr 4, 2023 RNL2

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Apr 4, 2023 89AG

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

Apr 3, 2023 EROP

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

Mar 31, 2023 PR89

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Mar 31, 2023 APRE

TEAS SECTION 8 & 9 RECEIVED

Sep 20, 2022 E89R

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Oct 1, 2021 REM2

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Oct 25, 2012 NA89

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Oct 25, 2012 RNL1

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Oct 25, 2012 89AG

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

Oct 17, 2012 89AF

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

Oct 17, 2012 EROP

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

Oct 17, 2012 PR89

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Oct 16, 2012 APRE

TEAS SECTION 8 & 9 RECEIVED

Sep 27, 2012 E89R

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Sep 27, 2012 TCCA

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Sep 27, 2008 C15A

ASSIGNED TO PARALEGAL

Sep 11, 2008 PLGL

TEAS SECTION 8 & 15 RECEIVED

Jul 23, 2008 E815

CASE FILE IN TICRS

Nov 8, 2007 CFIT

REVIEW OF CORRESPONDENCE COMPLETE

Sep 2, 2006 CORV

PAPER RECEIVED

Aug 15, 2006 MAIL

REGISTERED-PRINCIPAL REGISTER

Oct 1, 2002 R.PR

PUBLISHED FOR OPPOSITION

Jul 9, 2002 PUBO

NOTICE OF PUBLICATION

Jun 19, 2002 NPUB

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 16, 2002 CNSA

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 25, 2002 CRFA

NON-FINAL ACTION MAILED

Jan 9, 2002 CNRT

ASSIGNED TO EXAMINER

Dec 17, 2001 DOCK

Related Trademarks

More from this Owner

HYDEAWAY

CITRISOLV

CITRAD

More in Same Class

VIMEC

THERAPTOSIS

ADVANCIS PHARMACEUTICAL CORP.

Serial #76322643

WOMEN'S PAVILION

SANGRE PURA SANGRE LIMPIA